Former Stoke City players have paid tribute to club legend George Eastham at a memorial service to celebrate his ...

The deal, which features up to $385 million in milestones, gives Biogen exclusive rights to commercialize Stoke’s ...

The school leaders taking unprecedented action to ensure a safe learning environment with amenities in good working order ...

From my colleague Adam Feuerstein: Biogen and Stoke Therapeutics have signed a partnership agreement to co-develop and sell ...

Norwich City are unbeaten across their past eight league games against Stoke City (W5 D3), scoring 3+ goals in four of those ...

Biogen and Stoke partner on zorevunersen for Dravet syndrome, with a Phase 3 trial starting in 2025. Stoke gets $165 million ...

Stoke Holy Cross Community Hall was officially opened by Charles Bussey (right) and Glyn Davies (Image: Sonya Duncan) Plans to build a new pavilion date to 2014 but funding for the project was not ...

Norwich City boss Johannes Hoff Thorup looks ahead to Stoke at home.

In exchange for $165 million, Biogen now has access to zorevunersen, a potential first-of-its-kind treatment for Dravet ...

When you buy through links on our articles, Future and its syndication partners may earn a commission.

Discover Stoke Therapeutics' innovative RNA-based treatments like zorevunersen for Dravet syndrome, with a promising pipeline ...

Stoke Therapeutics Inc. (Nasdaq: STOK) has pulled in Biogen (Nasdaq: BIIB) to help it develop and commercialize a treatment ...